NRC Health Long-Term Debt, Maturity, Year Two
NRC Health (NRC) had Long-Term Debt, Maturity, Year Two of $4.12 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-03-05
- 2025-12-31: Long-Term Debt, Maturity, Year Two $4.12M.
- 2024-12-31: Long-Term Debt, Maturity, Year Two $4.94M.
- 2023-12-31: Long-Term Debt, Maturity, Year Two $7.72M.
- 2022-12-31: Long-Term Debt, Maturity, Year Two $4.76M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2025-12-31 | $4.12M 10-K · filed 2026-03-05 |
| 2024-12-31 | $4.94M 10-K · filed 2025-03-17 |
| 2023-12-31 | $7.72M 10-K · filed 2024-02-27 |
| 2022-12-31 | $4.76M 10-K · filed 2023-03-03 |
| 2021-12-31 | $4.53M 10-K · filed 2022-03-04 |
| 2020-12-31 | $4.31M 10-K · filed 2021-03-05 |
| 2019-12-31 | $4.92M 10-K · filed 2020-03-06 |
| 2018-12-31 | $4.42M 10-K · filed 2019-03-08 |
| 2018-09-30 | $3.71M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.71M 10-Q · filed 2018-08-09 |
| 2016-12-31 | $857.00K 10-K · filed 2017-03-03 |
| 2015-12-31 | $2.48M 10-K · filed 2016-03-04 |
| 2014-12-31 | $2.40M 10-K · filed 2015-03-04 |
| 2013-12-31 | $2.33M 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |